¥2,037.00
1.26%
Tokyo, Sep 29, 12:44 pm JST. Market open.
ISIN
JP3545110003
Symbol
6678

Techno Medica Co.,ltd. Stock price

¥2,063.00
+13.00 0.63% 1M
-272.00 11.65% 6M
-183.00 8.15% YTD
+83.00 4.19% 1Y
-62.00 2.92% 3Y
+321.00 18.43% 5Y
+451.00 27.98% 10Y
+959.67 86.98% 20Y
Tokyo, Closing price Mon, Sep 28 2026
+18.00 0.88%
ISIN
JP3545110003
Symbol
6678

Is Techno Medica Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥17.4b
Enterprise Value
¥8.7b
Net debt
positive
Cash
¥8.7b
Shares outstanding
6.7m
Valuation (TTM | estimate)
P/E
11.3
P/S
1.5 | -
EV/Sales
0.8 | -
EV/FCF
-
P/B
1.3
Dividends
DPS
¥68.00
Yield 1Y | 5Y
3.3% | 3.5%
Growth 1Y | 5Y
0.0% | 6.8%
Payout 1Y | 3Y
46.9% | 43.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥11.7b | -
EBITDA
-
EBIT
¥1.7b
Net Income
¥1.2b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
20.9% | -
EBITDA
-
EBIT
63.8%
Net Income
43.2%
Free Cash Flow
-
Margin
Gross
46.9%
EBITDA
-
EBIT
14.7%
Net
10.4%
Free Cash Flow
-
Financial Health
Equity Ratio
80.2%
Return on Equity
7.4%
ROCE
12.3%
ROIC
20.7%
Debt/Equity
0.0
More
EPS
¥182.1
FCF per Share
-
Short interest
-
Employees
244
Rev per Employee
¥46.1m

Financial data from Techno Medica Co.,ltd.

Jun '26
+/-
%
11,682 11,682
21% 21%
100%
- Direct Costs 6,202 6,202
26% 26%
53%
5,480 5,480
16% 16%
47%
- Selling and Administrative Expenses 3,572 3,572
3% 3%
31%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,715 1,715
64% 64%
15%
Net Profit 1,214 1,214
43% 43%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Techno Medica Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Techno Medica Co., Ltd. engages in the manufacture and sale of analytical and medical equipment. The company is headquartered in Yokohama, Kanagawa-Ken and currently employs 244 full-time employees. The company went IPO on 2003-09-17. The blood collection tube preparation apparatus business provides blood collection peripheral equipment, such as blood and urine collection automation reception equipment, among others, as well as blood tube preparation systems. The laboratory test apparatus business provides blood gas analysis apparatus, electrolyte analyzers, erythrocyte sedimetation rate measuring machines, among others. The consumable goods business provides blood collecting tubes, labels, sensor cards, calibration packs, among others, as well as maintenance services.

Head office Japan
CEO Mr. Saneyoshi
Employees 244
Website www.technomedica.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today